CASSANDRA PATULA: Open Payments
NPI 1699251652 · OSPREY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 55 payments from 19 companies in 2025. Trend: 2023 $1,558 · 2024 $1,385 · 2025 $1,395
Food & beverage: $1,300Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $218 |
| GENZYME CORPORATION | 4 | $136 |
| Galderma Laboratories, L.P. | 5 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $109 |
| Lilly USA, LLC | 4 | $105 |
| PFIZER INC. | 4 | $105 |
| ConvaTec Inc. | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $64 |
Products named: TREMFYA, DUPIXENT, ILUMYA, INNOVAMATRIX AC, EBGLYSS, Zoryve, NEMLUVIO, CIBINQO.
Industry payments across FL — which companies pay providers there.
